Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 11 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

18%

2 trials in Phase 3/4

Results Transparency

0%

0 of 8 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
5(71.4%)
Phase 3
1(14.3%)
Phase 4
1(14.3%)
7Total
N/A(5)
Phase 3(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (11)

Showing 11 of 11 trials
NCT00448513Not ApplicableCompleted

Effects of Tea Catechin Extracts on Oxidative Damage

Role: lead

NCT01361204Not ApplicableCompleted

Anti-stress Effect of Theanine on Students During Long-term Pharmacy Practices

Role: lead

NCT01594086Not ApplicableCompleted

Effects of Green Tea Consumption on Homocysteine Metabolism and Cognitive Dysfunction

Role: lead

NCT01225770Phase 3Unknown

Gargling With Green Tea for Prophylaxis of Influenza Infection in Teenagers

Role: lead

NCT00812448Not ApplicableCompleted

Catechin Containing Mask for the Prevention of Influenza Infection

Role: lead

NCT00692068Completed

Relations Between Residual Renal Function and Oxidative and Carbonyl Stress in Peritoneal Dialysis Patients

Role: collaborator

NCT00239213Not ApplicableCompleted

Catechin Gargling for Influenza Infection

Role: lead

NCT00309426Unknown

Effect of Fetuin A in Hemodialysis Patients

Role: lead

NCT00307996Phase 4Completed

The Effect of CoQ10 Administration on Hemodialysis Patients

Role: lead

NCT00307983Unknown

Effect of Malnutrition on the Prognosis in Hemodialysis Patients

Role: lead

NCT00161369Completed

Effect of Homocysteine and Asymmetric Dimethylarginine on Cardiovascular Events in Hemodialysis Patients

Role: lead

All 11 trials loaded